How to Buy Guardian Pharmacy Services Stock
Guardian Pharmacy Services Inc
Guardian Pharmacy Services is a medical care facility company located in Georgia, United States, which is part of the Healthcare sector, and is traded under the ticker GRDN on the NYSE exchange.
Guardian Pharmacy Services stock last closed at $19.69, down 2.81% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Medical Care Facilities industry by N/A percentage points. Guardian Pharmacy Services stock is currently +39.05% from its 52-week low of $14.16, and -26.83% from its 52-week high of $26.91.
At the moment, there are 63.29M GRDN shares outstanding. The market cap of GRDN is $1.25B. In the past 24 hours, 288,000 GRDN shares were traded.
How to Buy Guardian Pharmacy Services Stock
Not sure how to invest in Guardian Pharmacy Services stock? Here's how.
- Choose where to buy Guardian Pharmacy Services stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Guardian Pharmacy Services stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Choose your payment method and add your details.
- Research Guardian Pharmacy Services stock: The Guardian Pharmacy Services ticker symbol is GRDN. Is Guardian Pharmacy Services stock a good investment? Should you buy shares of GRDN? How do GRDN's underlying business fundamentals look? Do top analysts think Guardian Pharmacy Services is a good buy? Why has GRDN's stock price moved recently? (Hint: Our stock research tools can help you understand if GRDN is a good stock to buy).
- Place your GRDN buy order: Decide if you will purchase GRDN shares at the current market price or use a limit order to purchase GRDN stock at a particular price.
- Keep tabs on your GRDN position: Create a watchlist to the latest updates on your new investment in Guardian Pharmacy Services stock.
Step 1: Choose where to buy Guardian Pharmacy Services stock
You need an online brokerage account to access the NYSE market and buy GRDN stock.
Our recommended brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global financial markets: From Tech to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the right brokerage, you need to fill out some personal info so you are able to buy GRDN today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to create a new trading account.
- Submit your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have created your account on mobile trading apps, you need to deposit funds:
Watch the video below for more details transferring funds into your investment account.
Step 4: Research Guardian Pharmacy Services stock
After you have figured out the best place to buy Guardian Pharmacy Services stock, it's important to research their stock prior to investing, so you actually comprehend the risk as well as the upside.
Guardian Pharmacy Services stock data
Guardian Pharmacy Services Overview
WallStreetZen was created to help average investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on GRDN's stock page.
What is the fair value of GRDN stock?
Investors use many financial metrics, analyses, models, and charts to gauge GRDN's true value.
Using relative valuations methods:
- GRDN could be overvalued based on its P/B ratio of 7.98x, relative to Medical Care Facilities industry P/B ratio of 4.55x
You can do additional valuation analysis on GRDN's stock here.
GRDN Financial Health Summary
Signs that GRDN is financially healthy:
- There are more short-term assets than long-term liabilities on the GRDN balance sheet.
- There are more short-term assets than short-term liabilities on the GRDN balance sheet.
Signs that GRDN is not financially healthy:
- GRDN profit margin has gone down from 2% to -7% in the past year.
- GRDN has a relatively high debt to equity ratio of 1.09.
Is it a good time to buy GRDN stock, according to analysts?
Out of 1 sell side analysts who give forecasts on GRDN, the consensus analyst rating on GRDN is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Guardian Pharmacy Services stock forecast page.
GRDN Technicals
GRDN Performance Numbers
Last year, GRDN revenue was $1.28B. Over the past 1 years, GRDN's revenue has grown by 19.54% per year. This was faster than the Medical Care Facilities industry average of 7.15%.
Dig into GRDN's earnings and revenue performance here.
What are GRDN insiders up to?
Over the last year, executives and large shareholders at GRDN have sold more shares than they have bought.
John Ackerman, Director of GRDN, was the latest GRDN insider to sell. They sold $3,044,119.68 worth of GRDN shares on May 28, 2025.
Dig into more about who owns GRDN shares here.
Can I rely on GRDN as an income stream?
No, Guardian Pharmacy Services doesn't provide an income stream by paying out dividends.
What do other investors have to say about GRDN?
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your GRDN buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a particular price limit, place a limit order.
Click the Open Trade button and your broker will execute the order.
If you require additional help with buying stocks on eToro, watch the helpful video below:
Step 6: Keep tabs on your GRDN position
Now that you own some shares in GRDN, you'll want to keep up with your investment.
Put GRDN on a watchlist to get notified of the latest news about your GRDN stock.
GRDN Feed
How to Buy Stock in Guardian Pharmacy Services
To reiterate, here are the 6 steps to buy stock in Guardian Pharmacy Services:
- Choose where to buy Guardian Pharmacy Services stock
- Sign up for your brokerage account
- Deposit funds into your investment account
- Research Guardian Pharmacy Services stock
- Place your GRDN buy order
- Keep tabs on your GRDN position
If you need a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you want to monitor your new investment in Guardian Pharmacy Services, create a watchlist today.
More Articles You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.